Wells Fargo’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,565
Closed -$6.71K 7659
2024
Q1
$6.71K Sell
9,565
-721
-7% -$814 ﹤0.01% 5836
2023
Q4
$18K Buy
10,286
+439
+4% +$641 ﹤0.01% 5673
2023
Q3
$14.2K Buy
9,847
+3,227
+49% +$8.07K ﹤0.01% 5716
2023
Q2
$17.2K Sell
6,620
-87
-1% -$260 ﹤0.01% 5784
2023
Q1
$24.7K Buy
6,707
+1,748
+35% +$7.36K ﹤0.01% 5559
2022
Q4
$8.78K Buy
4,959
+1,218
+33% +$3.24K ﹤0.01% 5601
2022
Q3
$15K Buy
3,741
+402
+12% +$2.47K ﹤0.01% 5534
2022
Q2
$19K Sell
3,339
-15,554
-82% -$127K ﹤0.01% 5491
2022
Q1
$277K Sell
18,893
-6,775
-26% -$90.7K ﹤0.01% 4794
2021
Q4
$405K Sell
25,668
-11,336
-31% -$272K ﹤0.01% 4827
2021
Q3
$1.19M Sell
37,004
-5,443
-13% -$191K ﹤0.01% 4095
2021
Q2
$1.76M Buy
42,447
+8,052
+23% +$331K ﹤0.01% 3798
2021
Q1
$1.75M Buy
34,395
+22,714
+194% +$1.19M ﹤0.01% 3822
2020
Q4
$378K Sell
11,681
-2,463
-17% -$34.9K ﹤0.01% 4729
2020
Q3
$169K Sell
14,144
-2,087
-13% -$24.2K ﹤0.01% 5036
2020
Q2
$215K Buy
+16,231
New +$211K ﹤0.01% 4871

Other funds holding DMTK

Wells Fargo's DMTK Position: Q2 2024 in Review

Wells Fargo sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2024, closing a stake of 9,565 shares — an estimated $6.71K sold.

Wells Fargo first reported a position in DMTK in Q2 2020 and held it in 16 quarters. The position peaked at $1.76M in Q2 2021. 8 funds tracked by Wall St. Rank hold DMTK as of Q2 2024.

  • Wells Fargo reported no remaining DermTech, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 9,565 DermTech, Inc. Common Stock shares in Q2 2024, an estimated $6.71K.
  • Wells Fargo first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Wells Fargo's DermTech, Inc. Common Stock position peaked at $1.76M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.